Delivery Order SPE2DB20D2104-SPE2DB25FMSRZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $14,414.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a widely used injectable medication for the management of type 2 diabetes, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a $1,501.50 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens with an ultimate completion date of August 5, 2025. This non-set-aside contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,702.70 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $4,881.77 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of July 30, 2025. This is a firm fixed price, non-set-aside delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. Trulicity, a diabetes medication, represents one of the broad range of pharmaceutical products the company supplies through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $1,801.80. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes management pharmaceutical, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency awarded a $4,521.27 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $4,804.80 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 4, 2025, and performance to be executed at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal...
- The Defense Logistics Agency awarded a $1,383.93 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 1, 2025, with completion expected by August 4, 2025. This firm fixed-price contract, issued without set-aside designation, leverages AmerisourceBergen's established relationship with DLA through competitive procurement procedures. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSRZDelivery Order
The Defense Logistics Agency awarded a $1,762.92 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a injectable medication used in diabetes management, reflecting the pharmaceutical distributor's core role in supplying critical medical products to federal healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its established capability to meet competitive procurement requirements across multiple therapeutic domains for defense health and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/7/25 |